ST elevation myocardial infarction cardiac rehabilitation

Jump to: navigation, search

ST elevation myocardial infarction Microchapters

Home

Patient Information

Overview

Pathophysiology

Pathophysiology of Vessel Occlusion
Pathophysiology of Reperfusion
Gross Pathology
Histopathology

Causes

Differentiating ST elevation myocardial infarction from other Diseases

Epidemiology and Demographics

Risk Factors

Risk Stratification

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Chest X Ray

Cardiac MRI

Echocardiography

Coronary Angiography

Treatment

Pre-Hospital Care

Initial Care

Pre-Discharge Care

Long-Term Medical Therapy and Secondary Prevention

Case Studies

Case #1

Case #2

Case #3

Case #4

Case #5

ST elevation myocardial infarction cardiac rehabilitation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on ST elevation myocardial infarction cardiac rehabilitation

CDC on ST elevation myocardial infarction cardiac rehabilitation

ST elevation myocardial infarction cardiac rehabilitation in the news

Blogs on ST elevation myocardial infarction cardiac rehabilitation

Directions to Hospitals Treating ST elevation myocardial infarction

Risk calculators and risk factors for ST elevation myocardial infarction cardiac rehabilitation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (DO NOT EDIT) [1][2]

Class I
"1. Cardiac rehabilitation/secondary prevention programs, when available, are recommended for patients with STEMI, particularly those with multiple modifiable risk factors and/or those moderate- to high-risk patients in whom supervised exercise training is warranted. (Level of Evidence: B)"
"2. For all patients, it is recommended that risk be assessed with a physical activity history and/or an exercise test to guide prescription. (Level of Evidence: B)"
"3. For all patients, encouraging 30 to 60 minutes of moderate-intensity aerobic activity is recommended, such as brisk walking on most preferably all days of the week, supplemented by an increase in daily lifestyle activities (e.g., walking breaks at work, gardening, and household work). (Level of Evidence: B)"
Class IIb
"1. Encouraging resistance training 2 days per week may be reasonable. (Level of Evidence: C)"

2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction (DO NOT EDIT)[3]

Posthospitalization Plan of Care (DO NOT EDIT)[3]

Class I
"1. Posthospital systems of care designed to prevent hospital readmissions should be used to facilitate the transition to effective, coordinated outpatient care for all patients with STEMI.[4][5][6][7][8](Level of Evidence: B)"
"2. Exercise-based cardiac rehabilitation/secondary prevention programs are recommended for patients with STEMI.[9][10][11][12](Level of Evidence: B)"
"3. A clear, detailed, and evidence-based plan of care that promotes medication adherence, timely follow-up with the healthcare team, appropriate dietary and physical activities, and compliance with interventions for secondary prevention should be provided to patients with STEMI.(Level of Evidence: C)"
"4. Encouragement and advice to stop smoking and to avoid secondhand smoke should be provided to patients with STEMI.[13][14][15][16](Level of Evidence: A)"

Sources

  • The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [17]
  • The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction [2]
  • The AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. [18]
  • 2013 Revised ACCF/AHA Guidelines for the Management of ST-Elevation Myocardial Infarction[3]

Cardiac Rehabilitation Centers

In Alphabetical Order

References

  1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M et al. (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).". Circulation 110 (5): 588-636. doi:10.1161/01.CIR.0000134791.68010.FA. PMID 15289388.
  2. 2.0 2.1 Antman EM, Hand M, Armstrong PW, et al (January 2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078.
  3. 3.0 3.1 3.2 O'Gara PT, Kushner FG, Ascheim DD, et al. (December 2012). "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e3182742c84. PMID 23247303.
  4. Naylor M, Brooten D, Jones R, Lavizzo-Mourey R, Mezey M, Pauly M (June 1994). "Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial". Ann. Intern. Med. 120 (12): 999–1006. PMID 8185149.
  5. Coleman EA, Parry C, Chalmers S, Min SJ (September 2006). "The care transitions intervention: results of a randomized controlled trial". Arch. Intern. Med. 166 (17): 1822–8. doi:10.1001/archinte.166.17.1822. PMID 17000937.
  6. Young W, Rewa G, Goodman SG, et al. (October 2003). "Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomized controlled trial". CMAJ 169 (9): 905–10. PMID 14581307.
  7. Jack BW, Chetty VK, Anthony D, et al. (February 2009). "A reengineered hospital discharge program to decrease rehospitalization: a randomized trial". Ann. Intern. Med. 150 (3): 178–87. PMID 19189907.
  8. Lappé JM, Muhlestein JB, Lappé DL, et al. (September 2004). "Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program". Ann. Intern. Med. 141 (6): 446–53. PMID 15381518.
  9. Leon AS, Franklin BA, Costa F, et al. (January 2005). "Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation". Circulation 111 (3): 369–76. doi:10.1161/01.CIR.0000151788.08740.5C. PMID 15668354.
  10. Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS (June 2009). "Cardiac rehabilitation and survival in older coronary patients". J. Am. Coll. Cardiol. 54 (1): 25–33. doi:10.1016/j.jacc.2009.01.078. PMID 19555836.
  11. Taylor RS, Brown A, Ebrahim S, et al. (May 2004). "Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials". Am. J. Med. 116 (10): 682–92. doi:10.1016/j.amjmed.2004.01.009. PMID 15121495.
  12. Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ (May 2011). "Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community". Circulation 123 (21): 2344–52. doi:10.1161/CIRCULATIONAHA.110.983536. PMID 21576654.
  13. Wilson K, Gibson N, Willan A, Cook D (April 2000). "Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies". Arch. Intern. Med. 160 (7): 939–44. PMID 10761958.
  14. Thomson CC, Rigotti NA (2003). "Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease". Prog Cardiovasc Dis 45 (6): 459–79. doi:10.1053/pcad.2003.YPCAD15. PMID 12800128.
  15. Dawood N, Vaccarino V, Reid KJ, Spertus JA, Hamid N, Parashar S (October 2008). "Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success". Arch. Intern. Med. 168 (18): 1961–7. doi:10.1001/archinte.168.18.1961. PMID 18852396.
  16. Shah AM, Pfeffer MA, Hartley LH, et al. (October 2010). "Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction". Am. J. Cardiol. 106 (7): 911–6. doi:10.1016/j.amjcard.2010.05.021. PMID 20854949.
  17. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (August 2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)". Circulation 110 (9): e82–292. PMID 15339869.
  18. Thomas RJ, King M, Lui K, Oldridge N, Piña IL, Spertus J (October 2007). "AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services". Circulation 116 (14): 1611–42. doi:10.1161/CIRCULATIONAHA.107.185734. PMID 17885210.

Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox